Evidence map›Paper›PMID 41207874›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Brain banks in Latin America: Infrastructure for diagnosis, research, and scientific equity in Mexico and the Caribbean.

Nabil Itzi Luna-Viramontes, Alejandra Morlett-Paredes, Itzcoatl Ordoñez-Lozano, Fidel de la Cruz-López, Vanessa Esmeralda Gonzalez-Chavez, Genaro Vargas-Hernández, E G Pérez-Pérez, Rogelio E Méndez-Llaca, Ignacio Villanueva-Fierro, Roció Ortiz-Butron and 3 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nabil Itzi Luna-ViramontesNational Dementia BioBank, AMPAEYDEN A.C., Estado de México, México.
Alejandra Morlett-ParedesDeparment of neurociences, University of California, La Jolla, California, USA.
Itzcoatl Ordoñez-LozanoNational Dementia BioBank, AMPAEYDEN A.C., Estado de México, México.
Fidel de la Cruz-LópezDepartamento de Fisiología. Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, México.
Vanessa Esmeralda Gonzalez-ChavezNational Dementia BioBank, AMPAEYDEN A.C., Estado de México, México.
Genaro Vargas-HernándezPrograma Educativo Posgrado en Biotecnología, Universidad Politécnica de Pachuca unidad Zempoala, Pachuca, México.
E G Pérez-PérezDirección de Investigación, Innovación y posgrado. Universidad Politécnica de Pachuca, Zempoala, Hidalgo, México.
Rogelio E Méndez-LlacaNational Dementia BioBank, AMPAEYDEN A.C., Estado de México, México.
Ignacio Villanueva-FierroInstituto Politécnico Nacional. CIIDIR. Unidad Durango. Becario COFAA, Durango, México.
Roció Ortiz-ButronDepartamento de Fisiología. Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, México.
Mario Hernandes-AlejandroDepartamento de Bioingeniería, Unidad Profesional Interdisciplinaria de Biotecnología del Instituto Politécnico Nacional, México, México.
Linda Garcés-RamírezDepartamento de Fisiología. Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, México.
José Luna-MuñozNational Dementia BioBank, AMPAEYDEN A.C., Estado de México, México.ORCID 0000-0002-6927-913X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The establishment of brain banks is a strategic initiative to advance research on neurodegenerative diseases in Latin America. This article highlights the development, operations, and multidisciplinary framework of the National Dementia BioBank in Mexico and the National Brain Bank in the Dominican Republic. Both centers focus on the molecular characterization of pathological proteins central to Alzheimer's disease, such as tau and amyloid beta. Standardized protocols have been implemented for tissue donation, preservation, and post mortem analysis. Beyond supporting diagnostics and research, these centers promote scientific literacy and public engagement through traveling exhibitions and outreach initiatives. Together, these brain banking efforts enhance regional scientific capacity, strengthen international collaboration, and advance the representation of historically underserved populations. Their work contributes to a more equitable and globally relevant neuroscience landscape, positioning Latin America as a growing contributor to translational research in aging and dementia. HIGHLIGHTS: Creation of two national brain banks in Mexico (National Dementia BioBank) and the Dominican Republic (National Brain Bank-UNPHU) with standardized protocols for donation, preservation, and post mortem analysis of tau and amyloid beta under international parameters. Integration of advanced histopathological and molecular diagnostic platforms combining classical stains (H&E, Bielschowsky) with immunoperoxidase, multiplex immunofluorescence staining, confocal microscopy, and AI-powered automated analysis for quantification and recognition of topographic patterns. Design of an inclusive tissue collection model that prioritizes the genomic and sociocultural representation of mestizo, Afro-Caribbean, and Indigenous populations, reducing Eurocentric bias and enhancing the global validity of studies on Alzheimer's and other dementias. Development of a culturally sensitive, ethical, and neuroethical framework, with an informed consent process accessible in multiple languages and literacy levels, and safeguarding confidentiality through rigorous data coding. Implementation of innovative outreach strategies (traveling exhibitions, augmented/virtual reality, public lectures) to promote a culture of brain donation and democratize knowledge about neurodegeneration in diverse communities.

Indexed as

Biomedical ResearchBrainTissue BanksAlzheimer DiseaseCaribbean RegionDominican RepublicHumansLatin AmericaMexicoNeurodegenerative DiseasesAlzheimer's diseaseamyloid betabrain bankdementianeuropathologytau protein

Identifiers

PMID41207874
PMCPMC12597397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.